UAE MOHAP approves Spesolimab for GPP flares

The UAE Ministry of Health and Prevention (MOHAP) has approved the first and only therapy by Boehringer Ingelheim for the treatment of adult generalised pustular psoriasis flares.

Related Keywords

Ministry Of Health ,Dubayy ,United Arab Emirates ,Boehringer Ingelheim ,Ousama Alhaj ,European Commission ,Pustular Psoriasis ,General Manager ,Human Pharma ,Near East ,Tradearabia ,Rade Arabia ,Iddle East Trade News ,Cc Business News ,Ndustry News ,Trade News ,Usiness Directory ,Enders ,Roject News ,Remium Content ,